Laurie K. McNamara, Ph.D.
Affiliations: | 2009 | Integrated Graduate Program in the Life Sciences | Northwestern University, Evanston, IL |
Area:
Biochemistry, General BiophysicsGoogle:
"Laurie McNamara"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Daniel M. Watterson | grad student | 2009 | Northwestern | |
| (Structure and activity of human death associated protein kinase (DAPK): Nucleotide interactions.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McNamara LK, Brunzelle JS, Schavocky JP, et al. (2011) Site-directed mutagenesis of the glycine-rich loop of death associated protein kinase (DAPK) identifies it as a key structure for catalytic activity. Biochimica Et Biophysica Acta. 1813: 1068-73 |
| Zimmermann M, Atmanene C, Xu Q, et al. (2010) Homodimerization of the death-associated protein kinase catalytic domain: development of a new small molecule fluorescent reporter. Plos One. 5: e14120 |
| McNamara LK, Watterson DM, Brunzelle JS. (2009) Structural insight into nucleotide recognition by human death-associated protein kinase. Acta Crystallographica. Section D, Biological Crystallography. 65: 241-8 |
| McNamara LK, Schavocky JP, Brunzelle JS, et al. (2008) P3-304: Death associated protein kinase (DAPK): A calcium/calmodulin (CAM) regulator of neuronal apoptosis that is a drug discovery target for neurodegenerative disorders Alzheimer's & Dementia. 4: T611-T611 |
| Borders AS, McNamara LK, Roy SM, et al. (2008) P2-419: Development of novel protein kinase inhibitors as experimental therapeutics for neurodegenerative disorders Alzheimer's & Dementia. 4: T496-T496 |
| Munoz L, Ralay Ranaivo H, Roy SM, et al. (2007) A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. Journal of Neuroinflammation. 4: 21 |
| Watterson D, Ranaivo HR, Behanna H, et al. (2007) P-014: Improving the CNS drug discovery process: Case study with an integrative approach yielding novel potential disease-modifying therapies Alzheimer's & Dementia. 3: S99-S99 |